# Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

> **NCT00161980** · PHASE3 · COMPLETED · sponsor: **Baxter Healthcare Corporation**

## Conditions studied

- Breast Cancer
- Lumpectomy
- Mastectomy Plus Axillary Lymph Node Dissection
- Lymphatic Leakage

## Interventions

- **DRUG:** Fibrin Sealant VH S/D
- **PROCEDURE:** Surgical intervention alone without Fibrin Sealant VH S/D application

## Key facts

- **NCT ID:** NCT00161980
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** —
- **Final completion:** 2002-12
- **Target enrollment:** — (—)
- **Last updated:** 2006-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00161980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00161980, "Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00161980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*